ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,957.78
0.45%
Dow Jones
42,799.29
-0.10%
US Dollar vs MXN
20.22422
0.77%
Brent Oil
72.155
-0.77%
Bitcoin
93,542.11
-1.65%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Avantor Inc (AVTR)

  7. Avantor Inc (AVTR) Noticias

AVTR

Avantor (AVTR)

Avantor Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:AVTR
FechaHoraFuenteTítuloSímboloCompañía
20/11/202407:05PR Newswire (US)Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceNYSE:AVTRAvantor Inc
14/11/202412:28Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:AVTRAvantor Inc
14/11/202407:05PR Newswire (US)Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest ChallengesNYSE:AVTRAvantor Inc
06/11/202416:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
06/11/202416:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:AVTRAvantor Inc
06/11/202407:29Edgar (US Regulatory)Form 8-K - Current reportNYSE:AVTRAvantor Inc
06/11/202407:05PR Newswire (US)Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of DirectorsNYSE:AVTRAvantor Inc
25/10/202408:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:AVTRAvantor Inc
25/10/202405:07IH Market NewsUS Futures Rise; Oil Prices Edge HigherNYSE:AVTRAvantor Inc
25/10/202405:05PR Newswire (US)Avantor® Reports Third Quarter 2024 ResultsNYSE:AVTRAvantor Inc
23/10/202407:05PR Newswire (US)Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry ChallengesNYSE:AVTRAvantor Inc
18/10/202406:05PR Newswire (US)Avantor® Closes Previously Announced Divestiture of its Clinical Services BusinessNYSE:AVTRAvantor Inc
30/09/202407:05PR Newswire (US)Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality ManagementNYSE:AVTRAvantor Inc
27/09/202407:05PR Newswire (US)Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024NYSE:AVTRAvantor Inc
25/09/202408:05PR Newswire (US)Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase AgreementNYSE:AVTRAvantor Inc
23/09/202407:05PR Newswire (US)Avantor® Participates in BioProcess International 2024 Conference Scientific Program and ExhibitionNYSE:AVTRAvantor Inc
12/09/202407:05PR Newswire (US)Avantor® Achieves Bronze Medal from EcoVadis for Sustainability PerformanceNYSE:AVTRAvantor Inc
05/09/202413:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AVTRAvantor Inc
22/08/202407:05PR Newswire (US)Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNYSE:AVTRAvantor Inc
16/08/202406:35PR Newswire (US)Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private EquityNYSE:AVTRAvantor Inc
08/08/202407:05PR Newswire (US)Wheels Up Announces Gregory Summe to Join Board of DirectorsNYSE:AVTRAvantor Inc
26/07/202405:05PR Newswire (US)Avantor® Reports Second Quarter 2024 ResultsNYSE:AVTRAvantor Inc
23/07/202418:17PR Newswire (US)Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600NYSE:AVTRAvantor Inc
01/07/202407:05PR Newswire (US)Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® EndonucleaseNYSE:AVTRAvantor Inc
28/06/202407:05PR Newswire (US)Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024NYSE:AVTRAvantor Inc
21/06/202406:47PR Newswire (US)Avantor® Appoints Corey Walker as President of Laboratory SolutionsNYSE:AVTRAvantor Inc
18/06/202407:05PR Newswire (US)Avantor® Releases 2024 Science for Goodness Sustainability ReportNYSE:AVTRAvantor Inc
31/05/202415:29Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:AVTRAvantor Inc
29/05/202407:05PR Newswire (US)Avantor® to Participate in Goldman Sachs Global Healthcare ConferenceNYSE:AVTRAvantor Inc
21/05/202407:05PR Newswire (US)Avantor® to Participate in Bernstein's 40th Annual Strategic Decisions ConferenceNYSE:AVTRAvantor Inc
 Showing the most relevant articles for your search:NYSE:AVTR

Su Consulta Reciente

AMEX
XLF
Financial Select Sector
COIN
BTCUSD
Bitcoin
CCOM
US500
US 500
CCOM
OILBRENT
Brent Oil
COIN
DOGEUSD
Dogecoin
AMEX
SPY
SPDR S&P 500
COIN
AVAXUSD
Avalanche
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
COIN
XRPUSD
Ripple
COIN
SOLUSD
Solana
NYSE
MCD
McDonalds
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados